SEC 13F Intelligence

Managers / Q2 2021 · view latest →

Centerbridge Partners, L.P.

CIK 0001484836 · 375 PARK AVENUE, 11TH FLOOR, NEW YORK, NY, 10152 · 212 672 5000

Reported Value
$1.1B
Q2 2021
Positions
124
Filings on Record
33
2019–present window
Filed
Aug 16, 2021
original filing

Summary

Centerbridge Partners, L.P. reported $1.1B in U.S.-listed holdings across 124 positions for Q2 2021.

The portfolio is heavily concentrated: Gohealth alone accounts for 41.7% of reported value.

Compared with Q1 2021, the fund opened 24 new positions and exited 17.

Portfolio Metrics

Turnover
+11.3%
vs prior filed quarter
Top-10 Concentration
+95.6%
share of reported value
Largest Position
+41.7%
Gohealth
New / Exited
24 / 17
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $982MQ4 ’18Q1 ’19: $729MQ2 ’19: $815MQ3 ’19: $550MQ4 ’19: $618MQ4 ’19Q1 ’20: $412MQ2 ’20: $468MQ3 ’20: $894MQ4 ’20: $1.2BQ4 ’20Q1 ’21: $1.1BQ2 ’21: $1.1BQ3 ’21: $856MQ4 ’21: $1.8BQ4 ’21Q1 ’22: $1.6BQ2 ’22: $1.1BQ3 ’22: $875MQ4 ’22: $1.0BQ4 ’22Q1 ’23: $1.0BQ2 ’23: $642MQ3 ’23: $467MQ4 ’23: $604MQ4 ’23Q1 ’24: $623MQ2 ’24: $505MQ3 ’24: $478MQ4 ’24: $468MQ4 ’24Q1 ’25: $510MQ2 ’25: $434MQ3 ’25: $101MQ4 ’25: $59MQ4 ’25Q1 ’26: $61Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 51.9%Other: 47.2%ADR: 1.0%Equity WRT: 0.0%
  • Common Stock · 51.9% · $567M
  • Other · 47.2% · $516M
  • ADR · 1.0% · $11M
  • Equity WRT · 0.0% · $18,000

Quarter-over-Quarter Changes full breakdown →

vs Q1 2021 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
GTXGARRETT MOTION INCNEW+3.39M3.39M+$27M$27M
GDSGDS HLDGS LTDNEW+135.0K135.0K+$11M$11M
AF ACQUISITION CORNEW+600.0K600.0K+$6M$6M
LANDCADIA HOLDINGS IV INCNEW+500.0K500.0K+$5M$5M
BUILD ACQUISITION CORPNEW+450.0K450.0K+$4M$4M
SOARING EAGLE ACQUISITION CONEW+200.0K200.0K+$2M$2M
SPARTAN ACQUISITION CORP IIINEW+150.0K150.0K+$1M$1M
CF ACQUISITION CORP VINEW+150.0K150.0K+$1M$1M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2021

41 positions
#IssuerClass% PortfolioValueShares
1GOHEALTH INCCOM CL A41.71%$456M40.68M
2RADIUS GLOBAL INFRASTRCTRE ICOM CL A14.49%$158M10.93M
3THCTENET HEALTHCARE CORPhistory →COM NEW13.15%$144M2.15M
4GNKGENCO SHIPPING & TRADING LTDhistory →SHS10.24%$112M5.93M
5PCGPG&E CORPhistory →COM6.18%$68M6.65M
6CYHCOMMUNITY HEALTH SYS INC NEWhistory →COM3.32%$36M2.35M
7GTXGARRETT MOTION INChistory →COM2.47%$27M3.39M
8VECTOIQ ACQUISITION CORP IICOM CL A · *W EXP 01/07/2021.83%$20M2.34M
9ROOT INCCOM CL A1.24%$14M1.25M
10GDSGDS HLDGS LTDhistory →SPONSORED ADS0.97%$11M135.0K
11EIXEDISON INTLCOM0.76%$8M143.5K
12AF ACQUISITION CORCLASS A COM · *W EXP 03/23/2020.55%$6M800.0K
13LANDCADIA HOLDINGS IV INCCLASS A COM · *W EXP 03/29/2020.46%$5M625.0K
14BUILD ACQUISITION CORPCOM CLASS A · *W EXP 03/15/2020.41%$4M600.0K
15CC NEUBERGER PRINCIPAL HOLDNSHS CL A · *W EXP 99/99/9990.37%$4M480.0K
16SOARING EAGLE ACQUISITION COCL A SHS · *W EXP 02/23/2020.19%$2M240.0K
17CF ACQUISITION CORP IVCOM CL A · *W EXP 12/31/202 · *W EXP 02/18/2020.16%$2M296.7K
18ALTIMETER GROWTH CORP 2COM CL A0.14%$2M150.0K
19NOVUS CAPITAL CORPORATION IICOM CL A · *W EXP 02/02/2020.14%$2M200.0K
20SPARTAN ACQUISITION CORP IIICOM CL A · *W EXP 02/04/2020.14%$2M187.5K
21CF ACQUISITION CORP VICOM CL A · *W EXP 02/18/2020.13%$1M153.8K
22BIOTECH ACQUISITION COMPANYCL A SHS · *W EXP 11/30/2020.09%$1M150.0K
23SCP & CO HEALTHCARE ACQUSTNCOM CL A · *W EXP 01/27/2020.09%$1M150.0K
24COLICITY INCCOM CL A · *W EXP 02/24/2020.09%$1M120.0K
25HUDSON EXECUTIVE INVES IIICOM CL A · *W EXP 02/22/2020.09%$997,000120.0K
26DIAMONDHEAD HOLDINGS CORPCL A · *W EXP 01/28/2020.09%$997,000125.0K
27CROWN PROPTECH ACQUISITIONSSHS CL A · *W EXP 99/99/9990.09%$995,000133.3K
28RXR ACQUISITION CORPCLASS A COM · *W EXP 03/08/2020.09%$992,000120.0K
29CF ACQUISITION CORP VCL A · *W EXP 01/25/2020.08%$919,000129.0K
30FIGURE ACQUISITION CORP ICOM CL A · *W EXP 03/31/2020.05%$535,00075.0K
31ARES ACQUISITION CORPORATIONCOM CL A · "W EXP 99/99/9990.05%$513,00070.0K
32EQHAWEQ HEALTH ACQUISITION CORPCOM CL A · *W EXP 02/20/202 · *W EXP 02/02/2020.05%$501,00075.0K
33PROVIDENT ACQUISITION CORPCL A · *W EXP 01/08/2020.04%$425,000112.7K
34DUNE ACQUISITION CORP*W EXP 10/29/2020.01%$120,000150.0K
357GC & CO HOLDINGS INC*W EXP 12/23/2020.01%$84,00092.5K
36DEEP LAKE CAPITAL ACQUSTN CO*W EXP 01/04/2020.01%$55,00060.0K
37INSU ACQUISITION CORP III*W EXP 12/31/2020.00%$39,00033.3K
38HEALTHCARE CAPITAL CORP*W EXP 12/31/2020.00%$36,00050.0K
39FORTRESS CAPITAL ACQUISITION*W EXP 99/99/9990.00%$32,00030.0K
40HENNESSY CAPITAL INVS CORP V*W EXP 01/20/2020.00%$30,00012.2K
41NORTHERN STAR INVSTMNT CORP*W EXP 01/31/2020.00%$24,00010.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$61M3May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$59M2Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$101M4Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$434M9Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$510M11May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$468M13Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$478M15Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$505M17Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$623M20May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$604M20Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$467M25Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$642M27Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$1.0B29May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$1.0B34Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$875M62Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.1B67Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.6B71May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$1.8B111Feb 17, 2022RESTATEMENTchanges · EDGAR ↗
Q3 2021$856M108Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.1B124Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.1B109May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.2B36Feb 23, 2021RESTATEMENTchanges · EDGAR ↗
Q3 2020$894M23Nov 17, 202013F-HRchanges · EDGAR ↗
Q2 2020$468M33Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$412M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$618M17Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$550M22Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$815M20Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$729M26May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$982M37Feb 14, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 10 additional managers.

  • Centerbridge Credit Advisors, L.L.C.028-13862
  • Centerbridge Partners Holdings, LLC028-13861
  • Aronson Jeffrey028-13858
  • Gallogly Mark T028-13857
  • Centerbridge Special Credit Advisors, L.L.C.028-14395
  • Centerbridge Advisors, LLC028-15424
  • Centerbridge Special Credit Advisors II, L.L.C028-16779
  • Centerbridge Special Credit Advisors III, L.L.C.028-19382
  • Centerbridge Advisors II, LLC028-20085
  • Centerbridge Advisors III, LLC028-21012

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.